NeoGenomics enlists Hague Convention to depose two UK researchers for US challenge
Infringement defendant NeoGenomics says two UK-based oncologists were wrongly omitted by Natera as inventors of cancer detection technology that NeoGenomics simultaneously argues is ineligible for patenting. So far, neither researcher has...To view the full article, register now.
Already a subscriber? Click here to view full article